Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Salvi

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Orbit (Amsterdam, Netherlands)|October 21, 2009
Rituximab in the treatment of thyroid eye disease: science fiction?Mario Salvi, Guia Vannucchi, Irene Campi, et al.
Eye (London, England)|January 7, 2026
Horizon scanning from panel discussions at the EUGOGO Global TED Forum 2025 LondonVickie Lee, Mario Salvi, Anja Eckstein, et al.
The Cochrane Database of Systematic Reviews|November 28, 2018
Tocilizumab for thyroid eye diseaseShirin Hamed Azzam, Swan Kang, Mario Salvi, et al.
Ophthalmology|September 5, 2002
Classification and prediction of the progression of thyroid-associated ophthalmopathy by an artificial neural networkMario Salvi, Davide Dazzi, Isabella Pellistri, et al.
The Journal of Clinical Endocrinology and Metabolism|October 17, 2023
Response to Letter to the Editor From Lui et al: "Increased Risk of Thyroid Eye Disease Following COVID-19 Vaccination"Ilaria Muller, Dario Consonni, Erica Crivicich, et al.
The Journal of Clinical Endocrinology and Metabolism|August 25, 2023
Increased Risk of Thyroid Eye Disease Following Covid-19 VaccinationIlaria Muller, Dario Consonni, Erica Crivicich, et al.
Thyroid : Official Journal of the American Thyroid Association|February 13, 2013
Treatment of pretibial myxedema with dexamethazone injected subcutaneously by mesotherapy needlesGuia Vannucchi, Irene Campi, Danila Covelli, et al.
Thyroid Research|December 27, 2025
Successful outcome of Rituximab treatment based on lymphocyte immunophenotyping in active Thyroid Eye Disease: a case reportMirco Armenti, Sara Maioli, Chiara Riva, et al.
Thyroid : Official Journal of the American Thyroid Association|August 24, 2004
Onset of autoimmune hepatitis during intravenous steroid therapy for thyroid-associated ophthalmopathy in a patient with Hashimoto's thyroiditis: case reportMario Salvi, Guia Vannucchi, Francesco Sbrozzi, et al.
International Journal of Molecular Sciences|November 11, 2022
Microbiota Alterations in Patients with Autoimmune Thyroid Diseases: A Systematic ReviewNadia Sawicka-Gutaj, Dawid Gruszczyński, Natalia Zawalna, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Orbit (Amsterdam, Netherlands)|October 21, 2009
Rituximab in the treatment of thyroid eye disease: science fiction?Mario Salvi, Guia Vannucchi, Irene Campi, et al.
Eye (London, England)|January 7, 2026
Horizon scanning from panel discussions at the EUGOGO Global TED Forum 2025 LondonVickie Lee, Mario Salvi, Anja Eckstein, et al.
The Cochrane Database of Systematic Reviews|November 28, 2018
Tocilizumab for thyroid eye diseaseShirin Hamed Azzam, Swan Kang, Mario Salvi, et al.
Ophthalmology|September 5, 2002
Classification and prediction of the progression of thyroid-associated ophthalmopathy by an artificial neural networkMario Salvi, Davide Dazzi, Isabella Pellistri, et al.
The Journal of Clinical Endocrinology and Metabolism|October 17, 2023
Response to Letter to the Editor From Lui et al: "Increased Risk of Thyroid Eye Disease Following COVID-19 Vaccination"Ilaria Muller, Dario Consonni, Erica Crivicich, et al.
The Journal of Clinical Endocrinology and Metabolism|August 25, 2023
Increased Risk of Thyroid Eye Disease Following Covid-19 VaccinationIlaria Muller, Dario Consonni, Erica Crivicich, et al.
Thyroid : Official Journal of the American Thyroid Association|February 13, 2013
Treatment of pretibial myxedema with dexamethazone injected subcutaneously by mesotherapy needlesGuia Vannucchi, Irene Campi, Danila Covelli, et al.
Thyroid Research|December 27, 2025
Successful outcome of Rituximab treatment based on lymphocyte immunophenotyping in active Thyroid Eye Disease: a case reportMirco Armenti, Sara Maioli, Chiara Riva, et al.
Thyroid : Official Journal of the American Thyroid Association|August 24, 2004
Onset of autoimmune hepatitis during intravenous steroid therapy for thyroid-associated ophthalmopathy in a patient with Hashimoto's thyroiditis: case reportMario Salvi, Guia Vannucchi, Francesco Sbrozzi, et al.
International Journal of Molecular Sciences|November 11, 2022
Microbiota Alterations in Patients with Autoimmune Thyroid Diseases: A Systematic ReviewNadia Sawicka-Gutaj, Dawid Gruszczyński, Natalia Zawalna, et al.
Pageof 6